
1001 - 5000 employees
Founded 2014
𧬠Biotechnology
π Pharmaceuticals
π₯ Funding within the last year
π° $500M POST IPO EQUITY on 2026-04
Biotechnology β’ Pharmaceuticals
Revolution Medicines is an oncology company that discovers and develops targeted medicines for patients with RAS-addicted cancers. Its RAS(ON) tri-complex inhibitor platform supports a portfolio of investigational oral therapies designed to target the active, cancer-driving state of RAS.
π₯ 10 minutes ago
πΊπΈ United States β Remote
π΅ $232k - $290k / year
β° Full Time
π΄ Lead
π Director
π» Ghost score 0%
Where this job comes from
Posted on Revolution Medicines's careers page β, not through a job board
First seen by Remote Rocketship 10 minutes ago

1001 - 5000 employees
Founded 2014
𧬠Biotechnology
π Pharmaceuticals
π₯ Funding within the last year
π° $500M POST IPO EQUITY on 2026-04
Biotechnology β’ Pharmaceuticals
Revolution Medicines is an oncology company that discovers and develops targeted medicines for patients with RAS-addicted cancers. Its RAS(ON) tri-complex inhibitor platform supports a portfolio of investigational oral therapies designed to target the active, cancer-driving state of RAS.
β’ Own the global commercial market-shaping strategy for pancreatic cancer early detection, including high-risk identification, surveillance, symptom recognition, diagnostic work-up, and referral to multidisciplinary care. β’ Identify barriers and opportunities across the patient journey from first symptoms or high-risk status through imaging, testing, specialist referral, diagnosis, staging, and access to treatment. β’ Assess blood-based detection tests, molecular biomarkers, AI-enabled imaging, radiology tools, and other diagnostic approaches, translating evidence maturity and workflow requirements into commercial implications. β’ Develop a strategic map of academic centers, NCI and other research networks, healthcare delivery partners, technology and diagnostic companies, and patient advocacy organizations; recommend partnership opportunities. β’ Lead global market research, epidemiology and patient-flow analyses, screening/adoption scenarios, stage-shift assumptions, and assessments of the opportunity and investment required for earlier diagnosis. β’ Partner on compliant, unbranded disease-awareness, provider education, and patient-engagement strategies. β’ Collaborate on evidence needs, operational dependencies, and payer or health-system considerations for emerging detection approaches. β’ Translate insights from clinical, provider, genetics, oncology, and advocacy stakeholders into market-shaping priorities. β’ Coordinate with daraxonrasib and zoldonrasib early-stage commercial leaders on treatment pathways, molecular testing needs, and patient-identification opportunities. β’ Prepare executive-level recommendations, scenario analyses, milestones, and phased investment plans aligned with U.S. and key ex-U.S. perspectives. β’ Select and direct agencies, research vendors, and specialist partners; deliver integrated outputs within budget. β’ Apply digital, omnichannel, and data-driven approaches to ecosystem intelligence and disease education. β’ Travel up to 50%.
β’ Bachelorβs degree with at least 15 years, or advanced degree with at least 8 years, of progressive commercial experience in a biotechnology and/or pharmaceutical company, including strategic marketing and ideally sales. β’ Proven success developing and executing global commercial strategy and influencing cross-functional product or disease-area teams. β’ Demonstrated ability to derive actionable insights and analytics that inform innovative commercial strategies and investment decisions. β’ Strong leadership, with the ability to lead teams, collaborate effectively across functions, and influence without direct authority. β’ Excellent organizational skills and ability to prioritize effectively and deliver results within established timelines. β’ Strong clinical and scientific acumen; ability to translate preclinical and clinical data into commercial implications. β’ Excellent written, verbal, and executive communication skills; ability to represent Revolution Medicines effectively with external stakeholders. β’ Entrepreneurial mindset, comfort with ambiguity, and passion for improving outcomes for people with cancer. β’ Ability to assess the clinical, economic, and practical feasibility of screening, surveillance, and diagnostic strategies in a setting where scientific and commercial evidence continues to evolve. β’ Experience in pancreatic or other gastrointestinal cancers, oncology diagnostics, or development of new disease-area markets. β’ Experience with screening or surveillance initiatives, molecular diagnostics, liquid biopsy, imaging, or AI-enabled diagnostic pathways. β’ Experience building external alliances across industry, academic medicine, patient advocacy, and healthcare systems. β’ Prior involvement with a global oncology product launch or major market-creation initiative in a competitive environment. β’ Experience in a smaller, rapidly growing company with evolving operating models.
β’ Competitive cash compensation β’ Robust equity awards β’ Strong benefits β’ Significant learning and development opportunities β’ Up to 50% travel required
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
π₯ 14 minutes ago
Fluor data center estimating director leading cost planning, benchmarking, and proposal pricing. Directing estimating teams and developing staff for mega-sized infrastructure projects.
πΊπΈ United States β Remote
π΅ $160k - $302k / year
π° Post-IPO Equity on 2025-10
β° Full Time
π΄ Lead
π Director
π₯ 40 minutes ago
Campaign director running state and local ballot measure campaigns for the Proportional Representation Hub. Building coalitions and campaign systems to advance proportional representation and democracy reform.
π₯ 40 minutes ago
Senior Director guiding learning, evaluation and impact at Global Fund for Children. Building trust-based frameworks and organizational learning for children, youth and community partners worldwide.
πΊπΈ United States β Remote
π΅ $105k - $140k / year
β° Full Time
π Senior
π΄ Lead
π Director
π₯ 1 hour ago
UKG director scaling customer programs for its HR, payroll, and workforce-management platform. Driving customer adoption, engagement, value realization, and measurable outcomes.
π₯ 2 hours ago
Senior Director leading American Red Cross disaster preparedness, response, recovery, volunteers, and partnerships across multiple states. Coordinating division-wide operations and community resilience.